Zavicefta ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacterials za sistemsko uporabo, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Ceftazidim Kabi 2000 mg prašek za raztopino za injiciranje ali infundiranje স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ceftazidim kabi 2000 mg prašek za raztopino za injiciranje ali infundiranje

fresenius kabi deutschland gmbh - ceftazidim - prašek za raztopino za injiciranje/infundiranje - ceftazidim 2000 mg / 1 steklenica - ceftazidim

Ceftazidim Kabi 2000 mg prašek za raztopino za injiciranje ali infundiranje স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ceftazidim kabi 2000 mg prašek za raztopino za injiciranje ali infundiranje

fresenius kabi deutschland gmbh - ceftazidim - prašek za raztopino za injiciranje/infundiranje - ceftazidim 2000 mg / 1 steklenica - ceftazidim